DOI QR코드

DOI QR Code

MicroRNA-296-5p Promotes Invasiveness through Downregulation of Nerve Growth Factor Receptor and Caspase-8

  • Lee, Hong (Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University) ;
  • Shin, Chang Hoon (Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University) ;
  • Kim, Hye Ree (Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University) ;
  • Choi, Kyung Hee (Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University) ;
  • Kim, Hyeon Ho (Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University)
  • Received : 2016.11.10
  • Accepted : 2016.11.29
  • Published : 2017.04.30

Abstract

Glioblastomas (GBM) are very difficult to treat and their aggressiveness is one of the main reasons for this as well as for the frequent recurrences. MicroRNAs post-transcriptionally regulate their target genes through interaction between their seed sequence and 3'UTR of the target mRNAs. We previously reported that miR-296-3p is regulated by neurofibromatosis 2 (NF2) and enhances the invasiveness of GBM cells via SOCS2/STAT3. In this study, we investigated whether miR-296-5p, which originates from the same precursor miRNA as miR-296-3p, can increase the invasiveness of GBM cells. It was observed that miR-296-5p potentiated the invasion of various GBM cells including LN229, T98G, and U87MG. Through bioinformatics approaches, two genes were identified as miR-296-5p targets: caspase-8 (CASP8) and nerve growth factor receptor (NGFR). From results obtained from Ago2 immunoprecipitation and luciferase assays, we found that miR-296-5p downregulates CASP8 and NGFR through direct interaction between seed sequence of the miRNA and 3'UTR of the target mRNA. Knockdown of CASP8 or NGFR also increased the invasive ability of GBM cells, indicating that CASP8 and NGFR are involved in potentiation of invasiveness by miR-296-5p. Consistent with our findings, CASP8 was downregulated in brain metastatic lung cancer cells, which have a high level of miR-296-5p, compared to parental cells, suggesting that miR-296-5p may be generally associated with the acquisition of invasiveness. Collectively, our results implicate miR-296-5p as a potential cause of invasiveness in cancer and suggest it as a promising therapeutic target for GBM.

Keywords

References

  1. Barker, P.A. (2004). p75NTR is positively promiscuous: novel partners and new insights. Neuron 42, 529-533. https://doi.org/10.1016/j.neuron.2004.04.001
  2. Freije, W.A., Castro-Vargas, F.E., Fang, Z., Horvath, S., Cloughesy, T., Liau, L.M., Mischel, P.S., and Nelson, S.F. (2004). Gene expression profiling of gliomas strongly predicts survival. Cancer Res. 64, 6503-6510. https://doi.org/10.1158/0008-5472.CAN-04-0452
  3. Hopkins-Donaldson, S., Ziegler, A., Kurtz, S., Bigosch, C., Kandioler, D., Ludwig, C., Zangemeister-Wittke, U., and Stahel, R. (2003). Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation. Cell Death Differ. 10, 356-364. https://doi.org/10.1038/sj.cdd.4401157
  4. Hwang, S.J., Lee, H.W., Kim, H.R., Song, H.J., Lee, D.H., Lee, H., Shin, C.H., Joung, J.G., Kim, D.H., Joo, K.M., et al. (2015). Overexpression of microRNA-95-3p suppresses brain metastasis of lung adenocarcinoma through downregulation of cyclin D1. Oncotarget 6, 20434-20448. https://doi.org/10.18632/oncotarget.3886
  5. Hwang, S.J., Lee, H.W., Kim, H.R., Lee, H., Shin, C.H., Yun, S.I., Lee, D.H., Kim, D.H., Kim, K.K., Joo, K.M., et al. (2016). Ubiquitin-specific protease 4 controls metastatic potential through beta-catenin stabilization in brain metastatic lung adenocarcinoma. Sci. Rep. 6, 21596. https://doi.org/10.1038/srep21596
  6. Jin, H., Pan, Y., Zhao, L., Zhai, H., Li, X., Sun, L., He, L., Chen, Y., Hong, L., Du, Y., et al. (2007). p75 neurotrophin receptor suppresses the proliferation of human gastric cancer cells. Neoplasia 9, 471-478. https://doi.org/10.1593/neo.07175
  7. Johnston, A.L., Lun, X., Rahn, J.J., Liacini, A., Wang, L., Hamilton, M.G., Parney, I.F., Hempstead, B.L., Robbins, S.M., Forsyth, P.A., et al. (2007). The p75 neurotrophin receptor is a central regulator of glioma invasion. PLoS Biol. 5, e212. https://doi.org/10.1371/journal.pbio.0050212
  8. Lee, W.S., Kwon, J., Yun, D.H., Lee, Y.N., Woo, E.Y., Park, M.J., Lee, J.S., Han, Y.H., and Bae, I.H. (2014). Specificity protein 1 expression contributes to Bcl-w-induced aggressiveness in glioblastoma multiforme. Mol. Cells 37, 17-23. https://doi.org/10.14348/molcells.2014.2161
  9. Lee, H., Park, S., Kang, Y.S., and Park, S. (2015). EphA receptors form a complex with caspase-8 to induce apoptotic cell death. Mol. Cells 38, 349-355. https://doi.org/10.14348/molcells.2015.2279
  10. Lee, H., Hwang, S.J., Kim, H.R., Shin, C.H., Choi, K.H., Joung, J.G., and Kim, H.H. (2016). Neurofibromatosis 2 (NF2) controls the invasiveness of glioblastoma through YAP-dependent expression of CYR61/CCN1 and miR-296-3p. Biochim. Biophys. Acta 1859, 599-611. https://doi.org/10.1016/j.bbagrm.2016.02.010
  11. Li, C., Egloff, A.M., Sen, M., Grandis, J.R., and Johnson, D.E. (2014). Caspase-8 mutations in head and neck cancer confer resistance to death receptor-mediated apoptosis and enhance migration, invasion, and tumor growth. Mol. Oncol. 8, 1220-1230. https://doi.org/10.1016/j.molonc.2014.03.018
  12. Liang, Y., Diehn, M., Watson, N., Bollen, A.W., Aldape, K.D., Nicholas, M.K., Lamborn, K.R., Berger, M.S., Botstein, D., Brown, P.O., et al. (2005). Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc. Natl. Acad. Sci. USA 102, 5814-5819. https://doi.org/10.1073/pnas.0402870102
  13. Marchetti, D., Aucoin, R., Blust, J., Murry, B., and Greiter-Wilke, A. (2004). p75 neurotrophin receptor functions as a survival receptor in brain-metastatic melanoma cells. J. Cell. Biochem. 91, 206-215. https://doi.org/10.1002/jcb.10649
  14. Menter, D.G., Herrmann, J.L., Marchetti, D., and Nicolson, G.L. (1994). Involvement of neurotrophins and growth factors in brain metastasis formation. Invasion Metastasis 14, 372-384.
  15. Moore, L.M., and Zhang, W. (2010). Targeting miR-21 in glioma: a small RNA with big potential. Exp. Opin. Ther. Targets 14, 1247-1257. https://doi.org/10.1517/14728222.2010.527334
  16. Oberst, A., and Green, D.R. (2011). It cuts both ways: reconciling the dual roles of caspase 8 in cell death and survival. Nat. Rev. Mol. Cell Biol. 12, 757-763. https://doi.org/10.1038/nrm3214
  17. Ohgaki, H., and Kleihues, P. (2007). Genetic pathways to primary and secondary glioblastoma. Am. J. Pathol. 170, 1445-1453. https://doi.org/10.2353/ajpath.2007.070011
  18. Omuro, A., and DeAngelis, L.M. (2013). Glioblastoma and other malignant gliomas: a clinical review. Jama 310, 1842-1850. https://doi.org/10.1001/jama.2013.280319
  19. Pingoud-Meier, C., Lang, D., Janss, A.J., Rorke, L.B., Phillips, P.C., Shalaby, T., and Grotzer, M.A. (2003). Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma. Clin. Cancer Res. 9, 6401-6409.
  20. Quann, E.J., Khwaja, F., and Djakiew, D. (2007). The p38 MAPK pathway mediates aryl propionic acid induced messenger rna stability of p75 NTR in prostate cancer cells. Cancer Res. 67, 11402-11410. https://doi.org/10.1158/0008-5472.CAN-07-1792
  21. Reichardt, L.F. (2006). Neurotrophin-regulated signalling pathways. Philosophical transactions of the Royal Society of London. Series B, Biol. Sci. 361, 1545-1564.
  22. Sachs, B.D., Baillie, G.S., McCall, J.R., Passino, M.A., Schachtrup, C., Wallace, D.A., Dunlop, A.J., MacKenzie, K.F., Klussmann, E., Lynch, M.J., et al. (2007). p75 neurotrophin receptor regulates tissue fibrosis through inhibition of plasminogen activation via a PDE4/cAMP/PKA pathway. J. Cell Biol. 177, 1119-1132. https://doi.org/10.1083/jcb.200701040
  23. Stupack, D.G., Teitz, T., Potter, M.D., Mikolon, D., Houghton, P.J., Kidd, V.J., Lahti, J.M., and Cheresh, D.A. (2006). Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature 439, 95-99. https://doi.org/10.1038/nature04323
  24. Tabassum, A., Khwaja, F., and Djakiew, D. (2003). The p75(NTR) tumor suppressor induces caspase-mediated apoptosis in bladder tumor cells. Int. J. Cancer 105, 47-52. https://doi.org/10.1002/ijc.11038
  25. Teitz, T., Lahti, J.M., and Kidd, V.J. (2001). Aggressive childhood neuroblastomas do not express caspase-8: an important component of programmed cell death. J. Mol. Med. 79, 428-436. https://doi.org/10.1007/s001090100233
  26. Thomas, A.A., Brennan, C.W., DeAngelis, L.M., and Omuro, A.M. (2014). Emerging therapies for glioblastoma. JAMA Neurol. 71, 1437-1444. https://doi.org/10.1001/jamaneurol.2014.1701
  27. Wang, L., Rahn, J.J., Lun, X., Sun, B., Kelly, J.J., Weiss, S., Robbins, S.M., Forsyth, P.A., and Senger, D.L. (2008). Gamma-secretase represents a therapeutic target for the treatment of invasive glioma mediated by the p75 neurotrophin receptor. PLoS Biol. 6, e289. https://doi.org/10.1371/journal.pbio.0060289
  28. Wilson, N.S., Dixit, V., and Ashkenazi, A. (2009). Death receptor signal transducers: nodes of coordination in immune signaling networks. Nat. Immunol. 10, 348-355. https://doi.org/10.1038/ni.1714
  29. Winter, J., and Diederichs, S. (2011). MicroRNA biogenesis and cancer. Method Mol. Biol. 676, 3-22.

Cited by

  1. miR-296-5p suppresses EMT of hepatocellular carcinoma via attenuating NRG1/ERBB2/ERBB3 signaling vol.37, pp.1, 2018, https://doi.org/10.1186/s13046-018-0957-2
  2. MicroRNA induction by copy number gain is associated with poor outcome in squamous cell carcinoma of the lung vol.8, pp.1, 2018, https://doi.org/10.1038/s41598-018-33696-1
  3. MicroRNA-296: a promising target in the pathogenesis of atherosclerosis? vol.24, pp.1, 2018, https://doi.org/10.1186/s10020-018-0012-y
  4. MicroRNA-296-5p promotes healing of diabetic wound by targeting sodium-glucose transporter 2 (SGLT2) vol.35, pp.2, 2018, https://doi.org/10.1002/dmrr.3104
  5. CircPSMC3 suppresses the proliferation and metastasis of gastric cancer by acting as a competitive endogenous RNA through sponging miR-296-5p vol.18, pp.1, 2019, https://doi.org/10.1186/s12943-019-0958-6
  6. Five serum-based miRNAs were identified as potential diagnostic biomarkers in gastric cardia adenocarcinoma vol.23, pp.2, 2017, https://doi.org/10.3233/cbm-181258
  7. miR-296-5p inhibits IL-1β-induced apoptosis and cartilage degradation in human chondrocytes by directly targeting TGF-β1/CTGF/p38MAPK pathway vol.19, pp.12, 2017, https://doi.org/10.1080/15384101.2020.1750813
  8. Recent advances of the regulation roles of MicroRNA in glioblastoma vol.25, pp.7, 2017, https://doi.org/10.1007/s10147-020-01685-y
  9. miRNA signature in glioblastoma: Potential biomarkers and therapeutic targets vol.117, pp.None, 2020, https://doi.org/10.1016/j.yexmp.2020.104550
  10. MicroRNA-296-5p inhibits cell metastasis and invasion in nasopharyngeal carcinoma by reversing transforming growth factor-β-induced epithelial–mesenchymal transition vol.25, pp.1, 2020, https://doi.org/10.1186/s11658-020-00240-x
  11. The Value of miR-296 and miR-517c in Evaluating the Prognosis of Patients with Glioma after Radiotherapy and Chemotherapy vol.2021, pp.None, 2017, https://doi.org/10.1155/2021/6082458
  12. miR-296-5p Inhibits the Secretion of Pulmonary Surfactants in Pulmonary Epithelial Cells via the Downregulation of Wnt7b/ β -Catenin Signaling vol.2021, pp.None, 2017, https://doi.org/10.1155/2021/4051504
  13. Analysis of a Preliminary microRNA Expression Signature in a Human Telangiectatic Osteogenic Sarcoma Cancer Cell Line vol.22, pp.3, 2017, https://doi.org/10.3390/ijms22031163
  14. Downregulation of miR-296-3p by highly pathogenic porcine reproductive and respiratory syndrome virus activates the IRF1/TNF-α signaling axis in porcine alveolar macrophages vol.166, pp.2, 2017, https://doi.org/10.1007/s00705-020-04921-y
  15. MicroRNA‑296‑5p inhibits cell proliferation by targeting HMGA1 in colorectal cancer vol.22, pp.2, 2017, https://doi.org/10.3892/etm.2021.10225
  16. SOCS proteins and their roles in the development of glioblastoma (Review) vol.23, pp.1, 2017, https://doi.org/10.3892/ol.2021.13123